Research Article

Perinatal outcome of patients with placenta percreata

Volume: 5 Number: 3 December 15, 2020
EN TR

Perinatal outcome of patients with placenta percreata

Abstract

Aim: Placental invasion anomalies are rare, but it causes serious fetomaternal morbidity and mortality. In our study, we aimed to evaluate the fetomaternal results of cases with Abnormal Invasive Placenta ( Placenta Percreata). Methods: Patients who underwent a peripartum hysterectomy or whose placenta was left in uterin cavity due to placenta percreata in our hospital were retrospectively analyzed. Data of 20 patients were noted. Results: The mean age of the patients was ± SD (min-max) 33 ± 5,704 (25-46) and 60% (n = 12) of the patients had additional diseases. Fifty five percent of patients (n=11) were operated in emergency conditions and 45% (n = 9) in elective conditions. Surgical complications were 65% (n = 13) bladder injuries, 30% (n = 6) disseminated intravascular coagulation (DIC), 20% (n = 4) infection, 15% (n = 3) relapartomy and 5% (n = 1) was pulmonary embolism. Mortality increased three times (OR; 3.003 (95% CI, 0.372-24.390) in patients with a comorbidity, while 4.7 times (OR; 4.784) in emergency operations. Operations under elective conditions and previously ultrasonographic diagnosis (Odd ratio values ; 0,219 (95% CI, 0,021-2,447) and 0,615 (95% CI, 0,043-8,695), recpectively) decreased maternal mortality. Conclusion: Prenatal diagnosis and performing elective surgeries in percreata cases are important to reduce maternal mortality. Although there are various surgical complications, we think that DIC development is important in mortality and massive transfusion does not decrease the mortality.

Keywords

References

  1. Chan B, Lam H, Yuen J, et al. Conservative management of placenta praevia with accreta. Hong Kong Med J. 2008;14(6):479-84.
  2. Gielchinsky Y, Rojansky N, Fasouliotis S, et al. Placenta accreta—summary of 10 years: a survey of 310 cases. Placenta. 2002;23(2-3):210-214.
  3. Jauniaux E, Bunce C, Grønbeck L, et al. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2019.
  4. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa–placenta accreta. Am J Obstet Gynecol. 1997;177(1):210-214.
  5. Ye J, Zhang J, Mikolajczyk R, et al. Association between rates of caesarean section and maternal and neonatal mortality in the 21st century: a worldwide population‐based ecological study with longitudinal data. BJOG. 2016;123(5):745-753.
  6. Clausen C, Lönn L, Langhoff‐Roos J. Management of placenta percreta: a review of published cases. Acta Obstet Gynecol Scand. 2014;93(2):138-143.
  7. Cim N, Elci E, Sayan S, et al. Trends and causes of maternal mortality in Eastern province of Turkey. Eastern Journal Of Medicine. 2017;22(4):191.
  8. Chantraine F, Braun T, Gonser M, et al. Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand. 2013;92(4):439-444.

Details

Primary Language

English

Subjects

Surgery

Journal Section

Research Article

Publication Date

December 15, 2020

Submission Date

July 12, 2020

Acceptance Date

November 13, 2020

Published in Issue

Year 2020 Volume: 5 Number: 3

Vancouver
1.Erkan Elçi, Sena Sayan, Gülhan Elçi, Numan Çim. Perinatal outcome of patients with placenta percreata. Arch Clin Exp Med. 2020 Dec. 1;5(3):106-10. doi:10.25000/acem.768366